Search for: "Sanofi GmbH"
Results 1 - 20
of 72
Sort by Relevance
|
Sort by Date
23 Apr 2024, 10:28 am
Sanofi. [read post]
18 Oct 2023, 4:58 pm
Sep. 20, 2023), Baxalta Inc. and Baxalta GmbH (“Baxalta”) appealed from the U.S. [read post]
2 Aug 2023, 11:05 am
Sanofi further argued that the Board improperly shifted the burden of persuasion from Mylan to prove that the challenged claims were unpatentable to Sanofi to defend the claims of the ’614 patent as patentable. [read post]
15 Jul 2023, 6:00 am
DeJoy A 600/1 54 6/29/23 21-1043 Abitron Austria GmbH v. [read post]
15 Jul 2023, 6:00 am
DeJoy A 600/1 54 6/29/23 21-1043 Abitron Austria GmbH v. [read post]
15 Jun 2023, 2:20 pm
., Sanofi-Aventis Deutschland GmbH v. [read post]
25 May 2023, 6:00 am
In Sanofi-Aventis Deutschland GMBH v. [read post]
11 May 2023, 10:12 am
By Chris Holman Sanofi-Aventis Deutschland GMBH v. [read post]
31 Jan 2023, 2:59 pm
Abitron Austria GMBH v. [read post]
11 Nov 2022, 9:40 am
Sanofi, marking the first time that the Court has taken up patent law’s enablement requirement since enactment of the Patent Act of 1952. [read post]
6 Nov 2022, 2:18 pm
Abitron Austria GmbH v. [read post]
6 Nov 2022, 8:53 am
Sanofi. [read post]
4 Nov 2022, 1:02 pm
In Abitron Austria GmbH v. [read post]
2 Nov 2022, 11:43 am
Abitron Austria GmbH v. [read post]
26 Sep 2022, 4:49 am
Written Description for an Effective Treatment in Biogen International GmbH v. [read post]
1 Jul 2022, 10:02 am
Sanofi, No. 21-757. [read post]
29 Dec 2021, 4:16 pm
The outcome For the foregoing reasons, we affirm the four final written decisions that determined unpatentability based on Steenfeldt-Jensen: IPR2018-01670, IPR2018-01676, IPR2018-01678, and IPR2019-00979. [read post]
5 Oct 2020, 10:25 am
., No. 19-1452; Sanofi-Aventis Deutschland GmbH v. [read post]
5 Oct 2020, 2:00 am
Standard Verlags GmbH, the Judge started by recalling that the "close connection" criteria requires the same situation of fact and law. [read post]
27 Sep 2020, 6:36 pm
., No. 19-1452; Sanofi-Aventis Deutschland GmbH v. [read post]